Summary
The effects of thymoxamine 0.5% solution and of a placebo solution (mannitol) on the mydriasis induced by ibopamine 1% solution were evaluated in 8 healthy volunteers and 12 patients with eye diseases.
One drop of ibopamine was instilled into each eye and 30 min later 1 drop of thymoxamine was instilled into one eye and 1 drop of placebo into the contralateral eye. Pupillary diameter was measured before and 30 min after the instillation of ibopamine, immediately before the treatment with thymoxamine and placebo and 30, 60 and 90 min after the instillation of thymoxamine or of placebo.
Within 30 min of treatment, ibopamine had produced a statistically and clinically significant mydriatic effect. In eyes treated with thymoxamine, prompt reversal of mydriasis was observed, the baseline diameter being observed within 60 min.
No difference in the time-course of the mydriatic effect was detected between healthy subjects and patients. The pupillary response to thymoxamine was not influenced by the colour of the iris. The tolerability of ibopamine and of thymoxamine was good. No local or systemic adverse events were seen or reported.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Casagrande C, Ghirardi P, Marchetti G (1985) Ibopamine. In: Scriabine A (ed) New drugs annual: Cardiovascular Drugs, Vol. 3. Raven Press, New York
Henwood JM, Todd PA (1988) Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 36: 11–31
Ferrini R, Miragoli G (1986) Activity of ibopamine on some isolated organs. Arzneim-Forsch/Drug Res 36: 312–317
Virno M (1986) Studio sperimentale degli effetti locali e sistemici dell'ibopamina, farmaco dotato di attività adrenergica e dopaminergica. Boll Ocul 65: 1169–1185
Virno M, Taverniti L, Motolese E, Taloni M, Bruni P, Pecori Giraldi J (1986) Ibopamina: nuovo midriatico non cicloplegico (nota preliminare). Boll Ocul 65: 1135–1146
Gelmi C, Palazzuolo A, Lucchetti M, Trimarchi F (1989) Pupillographic evaluation of the mydriatic effect of ibopamine solution. Int J Clin Pharmacol Ther Tox 27: 346–351
Potter DE (1987) Drugs that alter autonomic nervous system function. In: Lamberts DW, Potter DE (eds) Clinical ophthalmic pharmacology, Little, Brown and Company, Boston/Toronto, 1st edn.
Lee DA, Rimele TJ, Brubaker RF, Nagataki S, Vanhoutte PM (1983) Effect of thymoxamine on the human pupil. Exp Eye Res 36: 655–662
Wand M, Grant WM (1980) Thymoxamine hydrochloride, an α-adrenergic blocker. A brief review. Surv Ophthalmol 25: 75–84
Small S (1976) Influence of thymoxamine on changes in pupil diameter and accommodation produced by homatropine and ephedrine. Br J Ophthalm 60: 132–134
Mayer GL (1977) Influence of alpha-adrenoceptor blockade with thymoxamine on changes in pupillary diameter and accommodation produced by tropicamide and ephedrine. Curr Med Res Opinion 4: 660–664
Lison L (1961) Statistica applicata alla biologia sperimentale. Casa Ed. Ambrosiana, Milano
Sears ML (ed) (1984) Handbook of experimental pharmacology: pharmacology of the eye, Vol. 69. Springer, Berlin Heidelberg New York
Spiers ASD, Calne DB, Vakil SD, French TM (1971) Action of thymoxamine on mydriasis induced by levodopa and dopamine. Br Med J 2: 438–439
Relf SJ, Gharagozloo NZ, Skuta GL, Alward WLM, Anderson DR, Brubaker RF (1988) Thymoxamine reverses phenylephrine induced mydriasis. Am J Ophthalmol 106: 251–255
Lee DA, Brubaker RF, Nagataki S (1981) Effect of thymoxamine on aqueous humor formation in the normal human eye as measured by fluorophotometry. Invest Ophthalmol Vis Sci 21: 805–811
Rutkowski PC, Fernandez JL, Galin MA, Halasa AH (1973) α-adrenergic receptor blockade in the treatment of angle-closure glaucoma. Trans Am Acad Ophthalmol Otolaryngol 77: 137–142
Wand M, Grant WM (1978) Thymoxamine test. Differentiating angle-closure glaucoma from open-angle glaucoma with narrow angles. Arch Ophthalmol 96: 1009–1011
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drago, F., Dal Bello, A., Marino, V. et al. Evaluation of the effect of thymoxamine solution 0.5% on mydriasis induced by ibopamine solution 1%. Eur J Clin Pharmacol 44, 477–480 (1993). https://doi.org/10.1007/BF00315547
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315547